[Pharmacotherapy of elderly patients]

[Personalised pharmacotherapy in intensive care unit patients]

Critically ill patients need fast, effective and safe pharmacotherapy. The pharmacokinetics and pharmacodynamics of the administered drugs are influenced by numerous individual conditions. Genetic factors mainly determines drug metabolism. However, therapeutic decisions are not yet guided by genetic analyses. In elderly patients, the volume of distribution can be altered and renal elimination may be delayed. Drug-drug interactions involving current medications can increase the incidence of adverse effects from treatment in the intensive care unit. In early severe sepsis, plasma levels of water-soluble drugs can be decreased because of enhanced volume of distribution and increased renal clearance. Later on, drug elimination can be impaired by deterioration of liver and renal function. Furthermore, the pharmacokinetic effects of continuous renal replacement therapy have to be considered. Plasma levels of critically ill patients show increased variability in comparison with healthy subjects or other patient groups. The therapeutic effect of antibiotics and of many other drugs cannot be assessed immediately. As dosage of these medications cannot be guided by their clinical efficacy, insufficient exposure or overdosage accompanied by toxic side effects may result. Standard dose recommendations that were developed in healthy volunteers or noncritically ill patients must be adapted to individual conditions and requirements of critically ill patients.

[Drug-drug interactions in the elderly : Which ones really matter?]

Pharmacotherapy in the elderly is challenging due to age-related physiological changes, high interindividual variability, and increasing frequency of multimorbidity. The resulting polypharmacy increases the risk of drug-drug interactions and requires an individual risk assessment. Some drug-drug interactions are documented to be associated with harm in older adults including intoxication, gastrointestinal bleeding, or falls. Therefore, they are considered to be of special importance in the elderly. Moreover, frequent risk factors and continuous physiological alterations in the elderly should be taken into account during risk assessment. This review exemplifies clinically relevant drug-drug interactions and risk factors in the elderly. In addition, assessment tools as well as prevention and management strategies for clinical practice are presented.

Acute confusional States in the elderly--diagnosis and treatment

BACKGROUND

Delirium is common, has multiple causes and causes distress to numerous patients and their relatives.

METHOD

Selective review of the literature in PubMed and PsycINFO, with reference to selected national and international guidelines.

RESULTS

The hypoactive subtype of delirium is commoner than the hyperactive type, and often overlooked. Delirium in an elderly individual is associated with an additional burden, a possible loss of potential for rehabilitation, and a marked increase in mortality. The diagnosis of delirium is primarily clinical. All professionals involved in patient care must be able to recognize the features of delirium. Dementia, dehydration and polypharmacy are particularly strongly associated, in the elderly. A careful history and examination with appropriate investigation allows underlying causes to be detected and treated. Rehabilitation strategies should be initiated without delay. Neuroleptics and benzodiazepines have an established role in the pharmacological treatment even of the hyperactive subtype. Non-pharmacological treatments include the creation of a calm and patient centred environment, and the involvement of relatives.

CONCLUSION

In many cases, delirium can be diagnosed and treated in good time. Prevention is preferable to treatment.

[Medication and falls in old age]

Falls with and without injuries in elderly persons commonly have multiple causes. Exposure to drugs does contribute to these causes. Therefore, complete assessment and evaluation of prescription and over the counter drugs are essential parts of fall-prevention concepts. Frail elderly persons frequently treated with several medications are particularly predisposed to adverse drug effects which may increase the risk of falling. Risk increasing drug effects are dose dependent which have been best studied with psychotropic medication. Apart from psychotropic drugs, cardiovascular drugs contribute to FRIDs (Fall-Risk Increasing Drugs). Fall risk is particularly increased with drugs of the same therapeutic class combined or combinations of psychotropics and cardiovascular drugs. Intervention studies on withdrawal and dose reduction of fall-risk increasing drugs were successful in reducing the risk of falling. There is relatively few knowledge on whether and how drug treatment does decrease fall risk in elderly patients by improving safe mobility and walking ability relevant to activities of daily living.